Institute of Health and
Biomedical Innovation
a university for the real world



Our cancer research area combines the activities of multidisciplinary research teams with the aim of improving outcomes for cancer patients.

We operate a strong collaborative research model where molecular and cellular biologists work alongside bioinformaticians, medicinal chemists, surgeons, oncologists and industrial partners to provide a real bench-to-bedside approach to tackling this disease.

Research programs

  • Prostate cancer
  • Breast cancer
  • Ovarian cancer
  • Endometrial cancer
  • Lung cancer
  • Melanoma



International linkages

  • Canada
  • Ireland
  • USA
  • Hong Kong
  • UK
  • New Zealand

Cross-disciplinary engagement

  • Biology
  • Biochemistry
  • Genomics
  • Bioinformatics
  • Clinical sciences
  • Medical physics
  • Public health
  • Cancer health services


Evidence of impact

  • Establishment of the multidisciplinary team clinic for advanced prostate cancer
  • Establishment of a Prostate Cancer Clinical Trials Unit at Princess Alexandra Hospital
  • Identification of prognostic biomarkers
  • Therapeutic development programs targeting gene targets including kallikreins, ID2, Daxx, YB-1, GADD45G, Ghrelin, EphB4, PAR2, tocotrienol and CDCP1
  • ihop Program – Improving Health Outcomes for People
  • Novel therapeutic approaches
  • Improved understanding of cancer biology

Research enquiries

IHBI research enquiries

Contact us to find out about research and discovery at the Institute of Health and Biomedical Innovation (IHBI).